Scenium

Neurology Nuclear Medicine Radiology

N/a
Regulatory Status Disclosed

Overview

Scenium, developed by Siemens Medical Solutions USA, Inc. (part of Siemens Healthineers), is an automated radiological image processing software. It is designed to add specific image processing and analysis capabilities to single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging systems. The software aids clinicians in the assessment and quantification of pathologies derived from PET and SPECT scans, particularly focusing on human brain scans. It enables automated analysis through the quantification of mean pixel values within standard regions of interest and facilitates comparison with existing scans and calculation of uptake ratios. Scenium is integrated into medical imaging workplaces as part of Siemens Healthineers’ AI-powered augmented workflow solutions, utilizing deep learning algorithms to support diagnostic precision. It is important to note that Scenium is a medical imaging analysis tool and not a physician directory tool.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated radiological image processing
  • Quantification of pathologies from PET and SPECT scans
  • Automated analysis of human brain scans
  • Quantification of mean pixel values in regions of interest
  • Comparison with existing FDG-PET, amyloid-PET, and SPECT studies
  • Calculation of uptake ratios between regions of interest
  • Visualization of multimodality data
  • Integration into medical imaging workplaces
  • Utilizes deep learning algorithms for abnormality detection and segmentation
  • Supports diagnostic precision

Use Cases

  • Assessment of brain pathologies in PET and SPECT scans
  • Quantification of imaging data for diagnostic purposes
  • Differentiation between normal and pathologic scans
  • Monitoring response to therapy (e.g., in oncology or neurology)
  • Augmenting clinical workflows in radiology and nuclear medicine

What Physicians Need to Know

Brain PET/SPECT Analysis
Scenium is a display and analysis software designed to aid clinicians in the assessment and quantification of pathologies from PET and SPECT brain scans. It offers workflows for database comparison, striatal analysis, cortical analysis, and subtraction, enabling automated analysis through quantification of mean pixel values within standard regions of interest. The software facilitates comparison with existing databases of normal patients and parameters from FDG-PET, amyloid-PET, and SPECT studies.
Seizure Detection
Scenium VE20 software includes dedicated workflows to assist clinicians in the visual evaluation, assessment, and quantification of pathologies related to seizure analysis, specifically for epilepsy, utilizing PET and SPECT scans.
Neurodegenerative Disease Screening
The software supports the assessment and quantification of pathologies such as dementia (e.g., Alzheimer's disease) and movement disorders (e.g., Parkinson's disease) from PET and SPECT scans. It achieves this by comparing patient data against a comprehensive database of 'normal' brain scans.
Physician Tip

Leverage Scenium's database comparison and quantitative analysis features for PET and SPECT scans to enhance diagnostic confidence in neurodegenerative diseases and seizure disorders. Utilize its specialized workflows for a standardized approach to evaluating pathologies like dementia and epilepsy, comparing patient data against normative databases for objective assessment.

Scenium VE20 analysis software is designed to run on commercially available software platforms, including Siemens syngo.MI Workflow software platform. This integration facilitates seamless data processing and workflow within existing medical imaging environments, supporting efficient data exchange and analysis.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing N/a
DeploymentIntegrated with medical imaging systems (on-premise/workstation-based), potentially with cloud integration for AI components.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status 1 AI-estimated

Scenium is cleared by the FDA under K251528 as 'Automated Radiological Image Processing Software', with a decision date of March 30, 2026. An earlier version, Scenium 2.0, was cleared under K113824 on April 9, 2012, for assessment and quantification of pathologies from PET and SPECT scans.

Integrations
EHR Not specified
Specialties Neurology, Nuclear Medicine, Radiology

What the Web Says

Scenium is a software solution by Siemens Healthineers designed to aid clinicians in the assessment and quantification of pathologies from PET and SPECT scans, particularly in neurology, including dementia, movement disorders, and epilepsy. It offers automated analysis through quantification of mean pixel values within standard regions of interest and correlates patient studies with a database of normal brain scans. The software is deployed via medical imaging workplaces and is organized into workflows specific to drug and disease combinations.

Overall: Positive

Strengths

  • Aids in the assessment and quantification of pathologies from PET and SPECT scans.
  • Enables automated analysis through quantification of mean pixel values.
  • Correlates patient studies with a comprehensive database of 'normal' brain scans.
  • Supports visualization and rendering of multimodality data.
  • Improves interreader agreement in interpreting PET brain scans.
  • Integrates with Siemens syngo.via MI Workflow software platform.

Limitations

  • Limited information available from independent tech reviewers, Reddit, G2, or Capterra.
  • Clinical testing was not conducted for some software updates, relying on predicate device comparisons.
  • Some studies using Scenium acknowledge potential biases or limitations in their methodologies.

Based on reviews from: BEUDAMED, accessdata.fda.gov, Siemens Healthineers, Imaging Technology News, Siemens Healthineers Academy, MDPI, Frontiers, American Journal of Neuroradiology, ResearchGate, International Atomic Energy Agency

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Scenium

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Scenium.

Loading videos...

View all on YouTube

Frequently Asked Questions

Scenium is a display and analysis software developed by Siemens for post-processing PET and SPECT brain scans. It aids clinicians in assessing and quantifying pathologies, facilitating automated analysis through quantification of mean pixel values within standard regions of interest, and enabling comparison with existing scans for conditions such as dementia, movement disorders, and epilepsy.
Yes, Scenium has received FDA 510(k) premarket notification clearance as a Class II medical device, indicating it is substantially equivalent to legally marketed predicate devices. While specific HIPAA details are not in the public FDA documents, medical software of this nature is expected to adhere to stringent data privacy regulations to protect patient health information.
Scenium is designed as a post-processing tool to aid clinicians in their assessment and quantification, not to replace their diagnostic judgment. As with any AI-powered analysis, its performance is dependent on the data it was trained on, and clinicians must critically review the automated results in the context of the patient's full clinical picture.
Scenium is deployed via medical imaging workplaces and is organized as a series of workflows specific to particular drug and disease combinations. It is intended to run on commercially available software platforms, such as the Siemens syngo.MI Workflow software platform, or directly on compatible Siemens scanners.
The FDA clearance documents for Scenium mention its substantial equivalence to predicate devices, indicating that other software exists for the visual evaluation, assessment, and quantification of pathologies derived from brain scans. While specific alternative product names are not detailed in the public records, the market includes various medical imaging analysis platforms with similar functionalities.
Specific pricing and licensing models for specialized medical software like Scenium are generally not publicly disclosed. Costs typically vary based on institutional size, the scope of implementation, included features, and support agreements, and are usually determined through direct negotiation with Siemens Medical Solutions.
Scenium's safety and effectiveness are ensured through its design and manufacturing processes, which comply with Quality System Regulations (21 CFR 820) and international standards such as ISO 14971 and ISO 62304. Verification and validation activities, along with risk management analyses, are performed throughout its development to ensure its performance.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

More from Siemens Medical Solutions USA

ACUSON Sequoia Diagnostic Ultrasound System
Siemens Medical Solutions USA
Radiology & Imaging AI
The ACUSON Sequoia Diagnostic Ultrasound System by Siemens Healthineers is a premium platform featuring BioAcoustic imaging, InFocus technology, and AI-powered tools to deliver consistent, high-resolution ultrasound imaging across diverse patient types and clinical applications.
AI Rad Companion (Engine)
Siemens Medical Solutions USA
Radiology & Imaging AI
Siemens AI-Rad Companion (Engine) is an FDA-cleared, AI-powered, cloud-based platform that streamlines radiology workflows and enhances diagnostic precision through automated image post-processing and structured reporting across multiple modalities.
AI-Rad Companion (Musculoskeletal)
Siemens Medical Solutions USA
Radiology & Imaging AI
AI-Rad Companion (Musculoskeletal) by Siemens Medical Solutions USA is an FDA-cleared AI-powered image processing software for quantitative and qualitative analysis of musculoskeletal conditions from CT DICOM images, supporting radiologists and physicians in diagnostic evaluation.
AI-Rad Companion Engine
Siemens Medical Solutions USA
Radiology & Imaging AI
The AI-Rad Companion Engine is an AI-powered, cloud-based platform by Siemens Medical Solutions USA that automates post-processing and enhances diagnostic precision in medical image interpretation across multiple modalities.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.